HomeXLO • NASDAQ
add
Xilio Therapeutics Inc
Previous close
$0.73
Day range
$0.72 - $0.75
Year range
$0.62 - $1.70
Market cap
38.16M USD
Avg Volume
803.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 8.08M | 242.98% |
Operating expense | 7.12M | 22.44% |
Net income | -15.84M | -13.78% |
Net profit margin | -195.99 | 66.83% |
Earnings per share | — | — |
EBITDA | -13.98M | 1.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 121.55M | 62.18% |
Total assets | 133.81M | 48.89% |
Total liabilities | 126.74M | 124.50% |
Total equity | 7.07M | — |
Shares outstanding | 51.83M | — |
Price to book | 5.21 | — |
Return on assets | -30.24% | — |
Return on capital | -216.36% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -15.84M | -13.78% |
Cash from operations | -14.48M | -172.56% |
Cash from investing | -401.00K | -1,809.52% |
Cash from financing | 47.36M | 136.30% |
Net change in cash | 32.48M | -18.74% |
Free cash flow | -100.75K | -100.32% |
About
Founded
2016
Headquarters
Website
Employees
64
